| Recruiting | A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808 | IDEAYA Biosciences | Phase 1 |
| Not Yet Recruiting | Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with En NCT06781216 | Akdeniz University | N/A |
| Recruiting | Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients NCT07318727 | Peking University People's Hospital | N/A |
| Completed | Tumor-Infiltrating Lymphocytes in Endometrial Cancer NCT06976333 | Jagiellonian University | — |
| Recruiting | A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer. NCT06841653 | Regina Elena Cancer Institute | — |
| Recruiting | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988 | Volastra Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | Development of a Molecular Diagnostic Tool for Endometrial Cancer. NCT06192017 | MiMARK Diagnostics, S.L. | — |
| Completed | Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer NCT06312917 | Peking University People's Hospital | N/A |
| Completed | Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer NCT05651282 | University of British Columbia | Phase 4 |
| Unknown | PET/CT in the Management of Patients With Early Stage Endometrial Cancer NCT03570866 | Università degli Studi dell'Insubria | — |
| Recruiting | Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment NCT06169449 | Peking University People's Hospital | N/A |
| Terminated | A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma NCT05036681 | M.D. Anderson Cancer Center | Phase 2 |
| Withdrawn | Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advance NCT04464967 | NKGen Biotech, Inc. | Phase 1 / Phase 2 |
| Completed | Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer. NCT04205864 | Kocaeli University | N/A |
| Unknown | Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma NCT03896113 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Phase 2 |
| Recruiting | Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR NCT04014530 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 1 / Phase 2 |
| Recruiting | Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model NCT04212910 | IRCCS San Raffaele | — |
| Unknown | Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer NCT03951415 | Leiden University Medical Center | Phase 2 |
| Completed | The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients NCT05246462 | Akdeniz University | N/A |
| Completed | Suspension of the Pelvic and Abdominal Organs During Minimally Invasive Surgery NCT06187558 | University of Cagliari | — |
| Completed | Relationship of Endometrial Cancer and Serum Soluble L1CAM Level NCT04603599 | Kocaeli University | — |
| Completed | Multimedia Aid Gynecologic Counseling and Consent NCT03899441 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Completed | Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer NCT04175067 | Muğla Sıtkı Koçman University | — |
| Completed | Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery NCT02997553 | Institut de Cancérologie de Lorraine | Phase 3 |
| Completed | Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. NCT03245736 | Seagen Inc. | Phase 2 |
| Suspended | Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors NCT03095664 | Brazilian National Cancer Institute | N/A |
| Completed | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors NCT02552121 | Seagen Inc. | Phase 1 / Phase 2 |
| Completed | Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. NCT02221076 | Mauna Kea Technologies | N/A |
| Active Not Recruiting | Predictive Clinical and Biological Parameters in Gynecological Cancer NCT01977274 | Institut Paoli-Calmettes | N/A |
| Completed | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors NCT02001623 | Seagen Inc. | Phase 1 / Phase 2 |
| Completed | ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers NCT01185626 | Lonneke van de Poll-Franse | N/A |
| Unknown | Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy NCT01466777 | Tampere University Hospital | N/A |
| Completed | Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients NCT01068483 | Novartis Pharmaceuticals | Phase 1 |
| Completed | A Trial for Patients With Advanced/Recurrent Endometrial Cancer NCT00377520 | Eli Lilly and Company | Phase 2 |